Chronotherapy Of Hypertension In Obstructive Sleep Apnoea
Funder
National Health and Medical Research Council
Funding Amount
$232,738.00
Summary
Obstructive Sleep Apnoea (OSA) is linked with excess cardiovascular disease, and this is partly attributed to increased high blood pressure (hypertension). Understanding how both conditions exacerbate hypertension and whether blood pressure control can be improved by altering the time that medication is taken will lead to improvements in health.
Chronotherapy For Hypertension In Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$253,229.00
Summary
Obstructive Sleep Apnea (OSA) is a common cause of hypertension, however treatment of OSA only results in a modest improvement in blood pressure (BP) and patients who are unable to tolerate treatment must rely on pharmacotherapy to control their BP. This study will definitively establish if altering the time of taking medication can improve BP control over 24 hours. The results will conribute to the development of more targeted treatment strategies for hypertension in people with OSA.